Foundation Medicine teams with IMS on precision medicine service

Foundation Medicine ($FMI) and IMS Health ($IMS) have teamed up to offer a precision medicine service. The alliance brings together Foundation Medicine's cancer genomics database and IMS' real-world evidence platform, a combination the partners think can enable the effective use of more targeted therapies. "This collaboration with Foundation Medicine extends our Real-World Evidence platform, uniquely linking claims, EMR and biomarker data at the anonymous patient level to ... improve clinical development and commercialization strategies," IMS VP Jon Resnick said in a statement. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.